6767 台微醫歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 76.79% | -7.10% | -9.34% | -9.33% |
| 2025Q1 | 78.94% | 3.53% | 6.30% | 6.30% |
| 2024Q4 | 78.29% | -14.53% | -16.57% | -16.60% |
| 2024Q3 | 79.16% | -10.48% | -10.74% | -10.74% |
| 2024Q2 | 78.98% | -13.38% | -11.82% | -11.82% |
| 2024Q1 | 78.82% | -20.21% | -19.79% | -19.79% |
| 2023Q4 | 78.66% | -12.15% | -9.87% | -9.80% |
| 2023Q3 | 78.75% | -6.44% | -14.14% | -13.45% |
| 2023Q2 | 79.39% | -2.86% | 10.26% | 10.04% |
| 2023Q1 | 78.32% | -4.29% | 18.59% | 17.79% |
| 2022Q4 | 77.67% | -7.14% | -9.63% | -9.63% |
| 2022Q3 | 76.75% | 3.90% | 4.13% | 4.12% |
| 2022Q2 | 74.18% | -1.78% | -9.30% | -9.35% |
| 2022Q1 | 73.59% | -17.11% | -22.14% | -22.19% |
| 2021Q4 | 71.53% | -18.63% | -4.56% | -4.56% |
| 2021Q3 | 74.09% | -13.46% | -20.50% | -20.50% |
| 2021Q2 | 70.19% | -26.47% | -45.94% | -45.94% |
| 2021Q1 | 65.95% | -45.82% | -81.75% | -81.75% |
| 2020Q4 | 66.89% | -38.64% | -50.30% | -50.30% |
| 2020Q3 | 69.82% | -38.46% | -74.02% | -74.02% |